PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma

Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data – speeding up drug development and aligning with the 21st Century Cures Act.

RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma®, PRA’s proprietary technology that allows for the generation of enhanced evidence for drug development. PRA’s solution makes it possible to connect clinical trial data and secondary data sets with privacy at the forefront. Today, three large pharmaceutical companies, along with several other pharmaceutical and biotech companies of all sizes, are using Synoma to link data and conduct analyses across their drug development portfolios.

“Data of all types is widely available from dozens of sources. The missing link, however, is the ability to connect clinical trial data to the insights from real-world data – enabling researchers to understand what is happening outside and after a study in a way that protects privacy,” said Kent Thoelke, Executive Vice President and Chief Scientific Officer, PRA Health Sciences. “Tokenization and linking is the approach researchers can use to glean the greatest insights into drug safety and effectiveness over time.”

PRA can partner with a variety of tokens to multiple sources of information – making it possible to incorporate broader sets of real-world data and revolutionize evidence generation and insights as envisioned by the 21st Century Cures Act.

“Tokenization of siloed patient data sets will be a game-changer for clinical researchers and drug developers,” said Jane Quigley, Senior Vice President, Digital Health, PRA Health Sciences. “Through our acquisition of Symphony Health and partnership with other data sources, we have enabled scientists and research teams to more intelligently evaluate a wider set of data to inform clinical trial protocols, leverage real-world data as eSource, conduct advanced feasibility, speed enrollment and, ultimately, bring novel and differentiated therapies to market faster.”

Contact us to learn more about how Synoma can be applied to clinical studies.

About PRA Health Sciences

PRA Health Sciences is one of the world’s leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes more than 75 offices across North America, Europe, Asia, Latin America, Africa, Australia and the Middle East and more than 19,000 employees worldwide. Since 2000, PRA has participated in approximately 4,000 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 95 drugs. To learn more about PRA, please visit


MEDIA INQUIRIES: Laurie Hurst, Sr. Director, Communications and Public Relations | +1 (919) 786-8435

Previous Article

مؤتمر الذكاء العالمي الخامس: في طليعة الابتكار

Next Article

‫ تجمع تمويلًا بقيمة 130 مليون دولار أمريكي لتوسيع نطاق منصتها الصحية الرقمية من أجل رعاية وأبحاث أفضل Huma

Related Posts

Cloud4C Has Earned the Windows Server and SQL Server Migration to Microsoft Azure Advanced Specialization

ABU DHABI, Feb. 16, 2022 /PRNewswire/ — Cloud4C today announced it has earned the Windows Server and SQL Server Migration to Microsoft Azure advanced specialization, a validation of a solution partner’s deep knowledge, extensive experience and expertise in migrating Windows Server and SQL Server-based workloads to Azure. Only partners that meet stringent criteria around customer success […]

‫إندونيسيا تنتظر الترحيب بالزوار الدوليينفي يوليو 2021

أعلنت وزارة الثقافة والسياحة الإندونيسية في “سوق السفر العربي دبي 2021” أن الاستعدادات جارية لاستقبال الزوار الدوليين هذا العام دبي، الإمارات العربية المتحدة، 2 يونيو 2021  /PRNewswire/ –أ أعلنت إندونيسيا اليوم أنها تتطلع إلى إعادة فتح حدودها جزئيًا أمام الزوار الدوليين.  تم الإعلان عن هذا في “سوق السفر العربي (ATM) دبي 2021″، وهو الحدث العالمي الرائد لقطاع السفر […]

‫شريكٌ قويٌّ ماليًا يدعم الالتزام المُستدام: الشيخ فلاح بن زايد آل نهيان يستثمر في بلامبيك الإماراتية

كوكسهافن ، ألمانيا, 4 مارس / آذار 2022 /PRNewswire/ — تلَّقى المشروع المشترك “بلامبيك الإماراتية العالمية للطاقة المتجددة – ذ م م”، الذي تأسس في العام 2011 ومقره في أبو ظبي، بمشاركة العائلة المالكة من أبو ظبي والشركة القابضة لرائد الأعمال نوربرت بلامبيك ومقرها كوكسهافن، دفعةً رأسمالية قوية بدخول الشيخ فلاح بن زايد آل نهيان […]

‫دَع هاتِف أوبو رينو8 برو  5Gيُنير الطريق لِصُنع لَحَظَات لا تُنسى

●  التقط لحظات لا تنسى في مهرجان ديوالي مع هاتف أوبو رينو 8 برو 5G . ●  صُمم ليكون خبير البورتريه، هاتف أوبو رينو 8 برو 5G يعيد تعريف القدرات التصويرية مع نظام كاميرا متطور ومدعوم بوحدة معالجة الصور MariSilicon X . ●  سيستمتع المستخدمين بتجربة تصوير ليلي فائق الوضوح و مليئة بالألوان الساطعة مع […]